In 2019, an independent review of the TGA's conformity assessment timeframes for medical devices in relation to those for other international regulators was undertaken.
While comparisons are difficult, our timeframes compare well internationally.
Conformity assessment (or equivalent) timeframes vary between jurisdictions, and while direct comparison is difficult due to differences in regulatory approaches, the TGA timeframes are broadly in line with comparable international regulators (Europe, Canada, UK, USA, Brazil and Singapore).
Therefore, no changes to statutory timeframes were made.
Only Australia split conformity assessment (or equivalent) and market authorisation. This split relates to the extensive use in Australia of approvals from recognised comparable overseas regulators. Other jurisdictions us fewer or no overseas approvals.